Birdwatch Note
2021-10-01 13:33:21 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There has been little to no evidence suggesting Ivermectin is an effective treatment or preventative measure against COVID-19 infection. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/ The FDA has already released a statement urging people to not take the drug in attempts to treat or prevent COVID-19 infection. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Written by F7E64318F15C87597C7936E4D1F75FB9
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1443914279145680901
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1443932046624133123
- noteId - 1443932046624133123
- participantId - F7E64318F15C87597C7936E4D1F75FB9
- noteAuthorParticipantId -
- createdAtMillis - 1633095201537
- tweetId - 1443914279145680901
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There has been little to no evidence suggesting Ivermectin is an effective treatment or preventative measure against COVID-19 infection. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/ The FDA has already released a statement urging people to not take the drug in attempts to treat or prevent COVID-19 infection. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2021-10-01 13:33:21 UTC (1633095201537) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
DD3ED1593FA524161424E18A8CAEC29329D389B62CB3E85DC83502BCBCE40A15 | ||
2021-10-01 13:33:21 UTC (1633095201537) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
F7E64318F15C87597C7936E4D1F75FB9 |
Note Ratings
rated at | rated by | |
2021-10-01 12:36:04 -0500 | 0DA8B88864F8F1EA1AF48084CCBADAC3 | Rating Details |
2021-10-06 23:25:52 -0500 | 0EA30680B0727B01D5EAE24F14ACBDB8 | Rating Details |
2021-10-04 05:16:12 -0500 | 1876C4C34E02274BC013B4C952618785674EA6A79DCAD1258AFC2751359E919E | Rating Details |
2021-10-04 15:27:29 -0500 | 1BEE401F9B2F36485995163FC9336DF1CDB288CEBD1AF86499BC1E6C2815A230 | Rating Details |
2021-10-01 17:58:18 -0500 | 1E08F0745EEC25A76F5C6302B0BDD3B66244EC8F6DA47A30C6010649F5B69E01 | Rating Details |
2021-10-02 20:23:41 -0500 | 1FCA930C2CA9A3F0A6BBC6824C8F202E | Rating Details |
2021-10-01 09:50:44 -0500 | 20EE153290447C507FC05314DEB4733F | Rating Details |
2021-10-05 05:16:15 -0500 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
2021-10-01 08:46:27 -0500 | 2411AB5FC8B507E2837742686630E1EAC8C6568BD4D083186D9F44F93B1C31D6 | Rating Details |
2021-10-02 18:58:55 -0500 | 25CB6B71146AEF46093B8078EBFE78D6 | Rating Details |
2021-10-04 22:58:33 -0500 | 267743C16BC7E08C217037372AC44A92 | Rating Details |
2021-10-01 12:53:27 -0500 | 2E7C722856F8344F247015CD5983B2FC | Rating Details |
2021-10-01 08:57:23 -0500 | 33EBACAA6801AE21B930B13377273DF7F253768987BBE74A27497004AE6D9707 | Rating Details |
2021-10-11 21:32:20 -0500 | 34CE9DB0BAADC3A031EC0BC854CDD2E2 | Rating Details |
2021-10-04 15:27:29 -0500 | 34E8E3D5159AAD1029C7E1A06DFD979B | Rating Details |
2021-10-01 08:41:05 -0500 | 399F030EB7A317B23E340EC7BACE09D6 | Rating Details |
2021-10-02 20:23:41 -0500 | 3BA3935478ECCB3472D612AA6602BB6D92BBB00AE8E61A3E933C58949897B3D6 | Rating Details |
2021-10-02 23:29:16 -0500 | 45713723439A0EA3576DA7DAF0CCBE53961F1E5339120FBC9681AC821249A13F | Rating Details |
2021-10-03 00:48:05 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
2021-10-01 09:38:40 -0500 | 47DAF3C92A96191B73F2D8D0A6B9F152 | Rating Details |
2021-10-01 12:46:53 -0500 | 52BBD27912001FBF3342F9776F75CD7F14656778D4F11EB2ED9201308CB5B7A5 | Rating Details |
2021-10-01 12:36:04 -0500 | 5302B4FD0ABD46F1334E8994CFB1D52AA406CC5689BE05D3B703C32FA0CE6E63 | Rating Details |
2021-10-16 17:25:34 -0500 | 53B255A91BE714E5FA97B410CCA15EC7 | Rating Details |
2021-10-01 15:30:25 -0500 | 5763BF42FC42EAC8B8B6DD9F60F9F3F2BA0E67F9E3B7625849BAAF4382B52C7D | Rating Details |
2021-10-16 17:25:34 -0500 | 5C1FACE7BE863C7C5B79B76B484318D71AA2630F16458E76F9D976A5C6B77325 | Rating Details |
2021-10-05 05:03:12 -0500 | 604228BA9EBAE4AF8672AFF8FCD1A9B2 | Rating Details |
2021-10-05 15:15:19 -0500 | 628C786C63B5A4D32E13C6C442E1863D | Rating Details |
2021-10-01 09:40:32 -0500 | 651E38A05976CFEFAD77A1D8E2728314 | Rating Details |
2021-10-01 12:53:27 -0500 | 6C4C785AB4F9B8FE33C06E92524F2880F0C88C563C25497910F116996C793A45 | Rating Details |
2021-10-04 14:44:54 -0500 | 728CE111EC46B498C98FBFA249F17170 | Rating Details |
2021-10-01 10:03:41 -0500 | 74A9B3E887DF8B365E561FC7777F8643442EBAC5AF92BE3CADEE582C1D40B1C8 | Rating Details |
2021-10-06 23:25:52 -0500 | 75640F2D508337E7439D9B45BDCB4BDC2EA68A177E4596486D33A667FA183DCD | Rating Details |
2021-10-04 14:44:54 -0500 | 7E8059953E828C7D1C20CD84B0B59EB1D04B8272B658A58E8D2EBD7412DC12ED | Rating Details |
2021-10-01 12:41:52 -0500 | 80A19FA586DD9CA1B90CF63A364FF0D0 | Rating Details |
2021-10-01 10:12:09 -0500 | 836174171387BD0C6F3B7AEF8C08D80D | Rating Details |
2021-10-01 09:50:44 -0500 | 8618E1E53F44C060890F1DA89354DB6F6E71662BE55D73A9010C546CCE822EA4 | Rating Details |
2021-10-04 11:51:45 -0500 | 8A7BCE25E117F08D75241FF91B9E71C3 | Rating Details |
2021-10-01 12:41:52 -0500 | 8B2FBCB2C724B66777EAEBF14BDD59B92016F7BD50C39119F9ED04192443AEFE | Rating Details |
2021-10-01 09:48:07 -0500 | 9017793278655F04DE0CDB888880BFEB | Rating Details |
2021-10-02 23:29:16 -0500 | 930449017C8602E843D239AC24E90587 | Rating Details |
2021-10-01 09:00:48 -0500 | 938AD16ED86A0D91AA3714ED16D261270A1710032387423D48E75AEAF262D5D8 | Rating Details |
2021-10-04 11:51:45 -0500 | 945B300A6FB42A1DB63CAF00C1D237751B292BA3B13678272038B3E024663C5F | Rating Details |
2021-10-01 15:30:25 -0500 | 9466B3AC539AF0E5099B5FA99E829C3A | Rating Details |
2021-10-03 00:48:05 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
2021-10-01 09:40:32 -0500 | 9CA8FD7859422700C6E655A4766193DF478B1D18943EE95CACCA98E9A971629C | Rating Details |
2021-10-01 09:00:48 -0500 | 9F4069F7B37AA09C958CF184AF2D5DE0 | Rating Details |
2021-10-01 17:58:18 -0500 | AC5230AE3E4CE1D21BC8FD9C16004FA5 | Rating Details |
2021-10-01 16:52:54 -0500 | AF5051BC3B07FBA9B4A002E7B1433913 | Rating Details |
2021-10-05 05:16:15 -0500 | B47391ADD314142E98ADB1447C70FB98 | Rating Details |
2021-10-11 21:32:20 -0500 | B6632C0206D16008A6D58872AD14BF223CD562B2DDB0AA99BE12290FC4D91B97 | Rating Details |
2021-10-01 12:02:57 -0500 | B8F5133B3E70B385C9FC0956D1DB3DC8 | Rating Details |
2021-10-01 10:43:56 -0500 | BCC153C030EC9B5550126408CCE61160 | Rating Details |
2021-10-01 11:39:53 -0500 | BDB1E0413DEEFEFE82A2BC1542915028 | Rating Details |
2021-10-01 10:12:09 -0500 | BE4D6C98CD88F481E8B6CC126D1EE77663FF732FA0E1A6EB77D3B11DE85705F6 | Rating Details |
2021-10-01 08:46:27 -0500 | C03D6A3AD0D9A670776CA30AC048BDA8 | Rating Details |
2021-10-01 10:14:47 -0500 | C46D0DF4D304650C0CCB2F1FF1D88471 | Rating Details |
2021-10-01 10:03:41 -0500 | C9A0AF65EF38BDC79B17AB4EF61EFBB8 | Rating Details |
2021-10-01 20:10:35 -0500 | CBD049435DBD4DF4F26B07D9A4683016 | Rating Details |
2021-10-05 05:03:12 -0500 | CE9C3A9979450E3DA35AE5CFFCD15408759819C89F16F2933512F9147E8AFB45 | Rating Details |
2021-10-01 12:46:53 -0500 | D16B4F7BC873E55F899B2BAE921A1BA6 | Rating Details |
2021-10-04 22:58:33 -0500 | D521C029AE36B49C0CC9B2510F4A0A99A00300565DBAA94F58C7A6233D46BD41 | Rating Details |
2021-10-01 09:48:07 -0500 | D73D5C0872605AACF0CB40F3C3724C95CE4A2BD9E10A339C56B8426E5E5FD3FC | Rating Details |
2021-10-04 05:16:12 -0500 | DB37D5233D86C5EBBEBF89DA095515E1 | Rating Details |
2021-10-01 08:57:23 -0500 | DB451066468F3F62AD9E64C68FE691FF | Rating Details |
2021-10-01 08:41:05 -0500 | DB5485CAF18DAEF5D67863569EEAB897728AE7883D590F0A1D3AC3464AB50AB3 | Rating Details |
2021-10-01 10:14:47 -0500 | DCC65FA5F7AC996539EA601BA63ECEE90613296F917C9F158A05CD3B06AE0E84 | Rating Details |
2021-10-01 10:43:56 -0500 | DFA8567592182105F38D65C1DF60C05B73F163FA987022FAC48EA457E4F8763E | Rating Details |
2021-10-02 18:58:55 -0500 | EDEFF5FAB6A7AA1684E87EFD5D7896CF29EED3BF68A139DE9CB356E0AF225A43 | Rating Details |
2021-10-01 16:52:54 -0500 | F216EF4CF9FBAF39130CBEC70A969BD77646C60E849C634D13858D0AD480297F | Rating Details |
2021-10-01 12:02:57 -0500 | F3FFB014AC5195ACEE4FBA6BD9F1FC564AEF0464EB973FEA3FED02C6E81B27D4 | Rating Details |
2021-10-05 15:15:19 -0500 | F8BAB6C36C94D458826C00923EC8142DC51DE19D541CBF847A78A7C7A85E2BE4 | Rating Details |
2021-10-01 09:38:40 -0500 | F8C5E774972D601545371BB760E50BC628456839AD7D0225D7B054A8EC2E77DA | Rating Details |
2021-10-01 11:39:53 -0500 | F9D480F623CA3C7885A8BBD00D4208B311091E911F433D067BAC0E028C7A56F4 | Rating Details |
2021-10-01 20:10:35 -0500 | FF81B2D229ABB08299941877255D5F789F6C1FEA7047C9F7E1BA7AC3F64857EA | Rating Details |
2021-10-16 17:25:34 -0500 | Rating Details | |
2021-10-01 10:43:56 -0500 | Rating Details | |
2021-10-01 12:46:53 -0500 | Rating Details | |
2021-10-06 23:25:52 -0500 | Rating Details | |
2021-10-11 21:32:20 -0500 | Rating Details | |
2021-10-01 17:58:18 -0500 | Rating Details | |
2021-10-02 20:23:41 -0500 | Rating Details | |
2021-10-01 08:41:05 -0500 | Rating Details | |
2021-10-01 12:41:52 -0500 | Rating Details | |
2021-10-01 20:10:35 -0500 | Rating Details | |
2021-10-01 09:00:48 -0500 | Rating Details | |
2021-10-05 05:03:12 -0500 | Rating Details | |
2021-10-01 09:50:44 -0500 | Rating Details | |
2021-10-01 10:12:09 -0500 | Rating Details | |
2021-10-01 10:03:41 -0500 | Rating Details | |
2021-10-01 09:48:07 -0500 | Rating Details | |
2021-10-05 15:15:19 -0500 | Rating Details | |
2021-10-02 18:58:55 -0500 | Rating Details | |
2021-10-01 12:36:04 -0500 | Rating Details | |
2021-10-01 15:30:25 -0500 | Rating Details | |
2021-10-04 05:16:12 -0500 | Rating Details | |
2021-10-01 12:53:27 -0500 | Rating Details | |
2021-10-01 08:57:23 -0500 | Rating Details | |
2021-10-04 22:58:33 -0500 | Rating Details | |
2021-10-01 11:39:53 -0500 | Rating Details | |
2021-10-01 09:38:40 -0500 | Rating Details | |
2021-10-04 15:27:29 -0500 | Rating Details | |
2021-10-02 23:29:16 -0500 | Rating Details | |
2021-10-01 08:46:27 -0500 | Rating Details | |
2021-10-04 11:51:45 -0500 | Rating Details | |
2021-10-01 12:02:57 -0500 | Rating Details | |
2021-10-01 10:14:47 -0500 | Rating Details | |
2021-10-01 09:40:32 -0500 | Rating Details | |
2021-10-05 05:16:15 -0500 | Rating Details | |
2021-10-01 16:52:54 -0500 | Rating Details | |
2021-10-04 14:44:54 -0500 | Rating Details | |
2021-10-03 00:48:05 -0500 | Rating Details |